0.2551

5.85% 0.0141

After Hours: .26 0.0049 +1.92%

Theriva Biologics Inc (TOVX)

Overview News Price History Discussions Forecast

Theriva Biologics Inc stock is traded at $0.2551, with a volume of 1.47M. It is up +5.85% in the last 24 hours and up +45.61% over the past month. Theriva Biologics, Inc., a clinical-stage company, develops therapeutics to treat diseases in areas of high unmet need. The company's lead product candidates include SYN-004 designed to degrade various commonly used intravenous beta-lactam antibiotics in gastrointestinal (GI) tract for the prevention of microbiome damage, clostridium difficile infection (CDI), overgrowth of pathogenic organisms, the emergence of antimicrobial resistance (AMR), and acute graft-versus-host-disease (aGVHD) in allogeneic hematopoietic cell transplant recipients; and SYN-020, a recombinant oral formulation for the enzyme intestinal alkaline phosphatase to treat both local GI and systemic diseases. It also develops VCN-01 for the treatment of patients with pancreatic cancer, head and neck squamous cell carcinoma, ovarian carcinoma, colorectal cancer, and retinoblastoma. In addition, the company develops clinical stage products, such as SYN-006 to prevent aGVHD and infection by carbapenem resistant enterococci; SYN-007 for preventing antibiotic associated diarrhea with oral ß-lactam antibiotics; SYN-005 for the prevention and treatment of pertussis; and VCN-11. It has collaborations with The University of Texas at Austin, and Cedars-Sinai Medical Center; and a clinical trial agreement with Washington University School of Medicine in St. Louis to conduct a Phase 1b/2a clinical trial of SYN-004. Theriva Biologics, Inc. is headquartered in Rockville, Maryland.

Previous Close:

$0.241

Open:

$0.245

24h Volume:

1.47M

Relative Volume:

0.13

Market Cap:

$11.71M

Revenue:

Net Income/Loss:

$-23.74M

P/E Ratio:

-0.0632

EPS:

-4.0366

Net Cash Flow:

$-16.70M

1W Performance:

-14.11%

1M Performance:

+45.61%

6M Performance:

-69.63%

1Y Performance:

-81.43%

1-Day Range:

$0.245

$0.2593

1-Week Range:

$0.2213

$0.28

52-Week Range:

$0.1628

$1.50

Theriva Biologics Inc Stock (TOVX) Company Profile

Name

Theriva Biologics Inc

Sector

Healthcare (1112)

Industry

Biotechnology (621)

Phone

301 417 4364

Address

9605 Medical Center Drive, Suite 270, Rockville

Employee

Twitter

Next Earnings Date

2026-03-12

Latest SEC Filings

TOVX's Discussions on Twitter

Compare TOVX vs VRTX, REGN, ARGX, ALNY, ONC

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
TOVX Theriva Biologics Inc	0.2551	11.06M	0	-23.74M	-16.70M	-4.0366
VRTX Vertex Pharmaceuticals Inc	441.70	113.01B	12.07B	3.95B	3.19B	15.33
REGN Regeneron Pharmaceuticals Inc	753.93	79.87B	14.34B	4.50B	3.77B	41.56
ARGX Argen X Se Adr	840.87	51.51B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	333.39	45.29B	3.71B	313.75M	465.38M	2.2571
ONC Beone Medicines Ltd Adr	319.94	34.41B	5.36B	287.73M	924.18M	2.5229

Theriva Biologics Inc Stock (TOVX) Latest News

Apr 11, 2026

CEO Moves: Is Theriva Biologics Inc subject to activist investor interest2026 Momentum Check & Free High Return Stock Watch Alerts - baoquankhu1.vn

Apr 11, 2026

Apr 10, 2026

TOVX Should I Buy - Intellectia AI

Apr 10, 2026

Theriva Biologics to reschedule stockholder meeting after lack of quorum By Investing.com - Investing.com Australia

Apr 10, 2026

Apr 09, 2026